Published in J Thorac Cardiovasc Surg on October 01, 1982
Tisseel® as a Reinforcement of Esophagojejunal Anastomoses | NCT03733639
The effectiveness of a fibrinogen-thrombin-collagen-based hemostatic agent in an experimental arterial bleeding model. Ann Surg (1987) 0.87
Fibrin adhesive: clinical application in coronary artery bypass graft surgery. Tex Heart Inst J (1985) 0.86
Surgical Materials: Current Challenges and Nano-enabled Solutions. Nano Today (2014) 0.81
Use of biological glue to control pulmonary air leaks. Thorax (1990) 0.76
Cardiopulmonary bypass established via a sutured vascular graft in the presence of extraanatomic bypass. Surg Today (1998) 0.75
Diagnosis and management of aortic dissection. Eur Heart J (2001) 5.39
Systemic inflammatory response syndrome after cardiac operations. Ann Thorac Surg (1996) 3.77
Intramural hemorrhage of the thoracic aorta. Diagnostic and therapeutic implications. Circulation (1995) 3.50
Extensive aortic replacement using "elephant trunk" prosthesis. Thorac Cardiovasc Surg (1983) 3.14
Attitude of patients toward transplantation of xenogeneic organs. Langenbecks Arch Surg (1999) 2.19
Expression of pig endogenous retrovirus by primary porcine endothelial cells and infection of human cells. Lancet (1998) 2.06
The superior approach to the mitral valve--is it worthwhile? Eur J Cardiothorac Surg (1988) 2.04
Coronary artery bypass grafting surgery without the routine application of blood products: Is it feasible? Eur J Cardiothorac Surg (2001) 2.02
Successful lung transplantation for posttraumatic adult respiratory distress syndrome after extracorporeal membrane oxygenation support. J Heart Lung Transplant (1992) 1.93
Extracorporeal membrane oxygenation in nonintubated patients as bridge to lung transplantation. Am J Transplant (2010) 1.87
Diagnosis of noninfective cardiac mass lesions by two-dimensional echocardiography. Comparison of the transthoracic and transesophageal approaches. Circulation (1991) 1.83
EuroSCORE overestimates the risk of cardiac surgery: results from the national registry of the German Society of Thoracic and Cardiovascular Surgery. Clin Res Cardiol (2009) 1.81
Monophasic action potential mapping in human subjects with normal electrocardiograms: direct evidence for the genesis of the T wave. Circulation (1987) 1.81
Selective attenuation of endothelium-mediated vasodilation in atherosclerotic human coronary arteries. Circ Res (1988) 1.77
Biocorrosion of magnesium alloys: a new principle in cardiovascular implant technology? Heart (2003) 1.76
Different approaches for minimally invasive closure of atrial septal defects. Ann Thorac Surg (1999) 1.75
Use of the "elephant trunk technique" in aortic surgery. Ann Thorac Surg (1995) 1.56
Myocardial calcification after orthotopic heart transplantation. J Heart Transplant (1988) 1.53
Phenotyping established chronic lung allograft dysfunction predicts extracorporeal photopheresis response in lung transplant patients. Am J Transplant (2013) 1.49
Inhibition of complement activation by pexelizumab reduces death in patients undergoing combined aortic valve replacement and coronary artery bypass surgery. J Thorac Cardiovasc Surg (2006) 1.48
Bronchial circulation after experimental lung transplantation. The effect of long-term administration of prednisolone. J Thorac Cardiovasc Surg (1993) 1.47
Listing for lung transplantation: life expectancy and transplant effect, stratified by type of end-stage lung disease, the Eurotransplant experience. J Heart Lung Transplant (2001) 1.47
Open heart operations after renal transplantation. Ann Thorac Surg (1997) 1.46
A new minimally invasive approach to the subclavian artery. Ann Thorac Surg (1998) 1.46
Therapy for lung failure using nitric oxide inhalation and surfactant replacement. Ann Thorac Surg (1996) 1.45
Clinical evaluation of transtracheal Doppler for continuous cardiac output estimation. Anesth Analg (1992) 1.45
Cardiac surgery in Germany during 2008. A report on behalf of the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg (2009) 1.45
Ten year survival after heart transplantation: palliative procedure or successful long term treatment? Heart (1999) 1.43
Matched-pair analysis of conventional versus endoluminal AAA treatment outcomes during the initial phase of an aortic endografting program. J Endovasc Ther (2000) 1.40
Preoperative corticosteroids. A contraindication to lung transplantation? Chest (1992) 1.39
Retrograde versus antegrade crystalloid cardioplegia in coronary surgery: value of troponin-I measurement. Ann Thorac Surg (2001) 1.39
Hyperacute rejection in heart allografts. Case studies. Pathol Res Pract (1991) 1.39
Explantation of the heart for resection of primary cardiac tumors can be avoided by partial ex situ heart surgery. Thorac Cardiovasc Surg (2003) 1.39
Coarctation of the aorta in complex congenital heart disease: simultaneous repair via sternotomy. Eur J Cardiothorac Surg (1990) 1.39
[Regional hyperthermic fibrinolytic perfusion in postoperative deep venous thrombosis of the leg]. Dtsch Med Wochenschr (1992) 1.38
Rapid identification of viral infections in liver, heart, and kidney allograft biopsies by in situ hybridization. Am J Surg Pathol (1989) 1.38
305 cases of permanent intravenous pacemaker treatment for Adams-Stokes syndrome. Surgery (1966) 1.38
Repair of flail anterior leaflets of tricuspid and mitral valves by cusp remodeling. Ann Thorac Surg (1990) 1.37
Tissue engineering of heart valves--human endothelial cell seeding of detergent acellularized porcine valves. Eur J Cardiothorac Surg (1998) 1.36
Perioperative complications in combined aortic valve replacement and extraanatomic ascending-descending bypass. Ann Thorac Surg (1996) 1.36
Tissue engineering of pulmonary heart valves on allogenic acellular matrix conduits: in vivo restoration of valve tissue. Circulation (2000) 1.35
Productive infection of primary human endothelial cells by pig endogenous retrovirus (PERV). Xenotransplantation (2000) 1.25
Bleeding management with fibrinogen concentrate targeting a high-normal plasma fibrinogen level: a pilot study. Br J Anaesth (2009) 1.24
Chronic hepatitis e in heart transplant recipients. Am J Transplant (2012) 1.18
Site of pleural drain insertion and early postoperative pulmonary function following coronary artery bypass grafting with internal mammary artery. Chest (1999) 1.18
Bridge to thoracic organ transplantation in patients with pulmonary arterial hypertension using a pumpless lung assist device. Am J Transplant (2009) 1.15
Regional distribution of beta-adrenoceptors in the human heart: coexistence of functional beta 1- and beta 2-adrenoceptors in both atria and ventricles in severe congestive cardiomyopathy. J Cardiovasc Pharmacol (1987) 1.14
Management and outcomes after multiple corneal and solid organ transplantations from a donor infected with rabies virus. Clin Infect Dis (2010) 1.13
Which is the best surgery for Budd-Chiari syndrome: venous decompression or liver transplantation? A single-center experience with 50 patients. Hepatology (1995) 1.13
Guided tissue regeneration of vascular grafts in the peritoneal cavity. Circ Res (2002) 1.12
Transposition of the greater omentum for management of mediastinal infection following orthotopic heart transplantation: a case report. J Heart Transplant (1987) 1.11
Thoracic aortic aneurysms after acute type A aortic dissection: necessity for follow-up. Ann Thorac Surg (1990) 1.08
Bronchoalveolar lavage in lung transplantation. State of the art. Clin Transplant (1999) 1.08
In vivo evaluation of the Lillehei-Kaster heart valve prosthesis. Ann Thorac Surg (1976) 1.07
Impact of preoperative aortic root diameter on long-term aortic valve function after valve sparing aortic root reimplantation. Circulation (2003) 1.06
Dire consequences of the indiscriminate use of Teflon felt pledgets. J Thorac Cardiovasc Surg (1987) 1.06
Cardiac surgery beyond the Urals. Eur J Cardiothorac Surg (1998) 1.06
Extraanatomic thoracic aortic bypass grafts: indications, techniques, and results. Eur J Cardiothorac Surg (1997) 1.05
Functional results after aortic valve repair in aortic root ectasia. J Heart Valve Dis (1996) 1.05
Acute and chronic aortic dissections--determinants of long-term outcome for operative survivors. Circulation (1985) 1.04
Microvesicles as novel biomarkers and therapeutic targets in transplantation medicine. Am J Transplant (2011) 1.04
Medical compared with surgical treatment for massive pulmonary embolism. Lancet (1994) 1.03
A novel full-scale flat membrane bioreactor utilizing porcine hepatocytes: cell viability and tissue-specific functions. Biotechnol Prog (2000) 1.02
Shuttle of lentiviral vectors via transplanted cells in vivo. Gene Ther (2005) 1.02
Steal phenomenon caused by a parallel branch of the internal mammary artery. Ann Thorac Surg (1990) 1.02
Complications of permanent transvenous cardiac pacing. J Thorac Cardiovasc Surg (1975) 1.01
Increased messenger RNA level of the inhibitory G protein alpha subunit Gi alpha-2 in human end-stage heart failure. Circ Res (1992) 1.01
Improved endothelial cell attachment on ePTFE vascular grafts pretreated with synthetic RGD-containing peptides. Eur J Vasc Endovasc Surg (1996) 1.00
Influence of mitral valve surgery on tricuspid incompetence concomitant with mitral valve disease. Circulation (1980) 0.98
Treatment of acute myocardial infarction by transmural blood supply from the ventricular cavity. Eur Surg Res (1971) 0.98
Flush perfusion with low potassium dextran solution improves early graft function in clinical lung transplantation. Eur J Cardiothorac Surg (2001) 0.97
Laser printing of cells into 3D scaffolds. Biofabrication (2010) 0.97
Effects of minimal invasive coronary artery bypass on pulmonary function and postoperative pain. Ann Thorac Surg (2000) 0.97
Porcine endogenous retrovirus (PERV) was not transmitted from transplanted porcine endothelial cells to baboons in vivo. Transpl Int (1998) 0.97
Surgical treatment of active infective endocarditis with paravalvular involvement. J Thorac Cardiovasc Surg (1994) 0.97
Tissue engineering of vascular grafts: human cell seeding of decellularised porcine matrix. Eur J Vasc Endovasc Surg (2000) 0.96
Predictors of proximal aortic dissection at the time of aortic valve replacement. Circulation (1999) 0.96
Immunosuppressive therapy after human lung transplantation. Eur Respir J (2004) 0.96
Proximal aortic dissection late after aortic valve surgery: 119 cases of a distinct clinical entity. Thorac Cardiovasc Surg (2000) 0.96
Microcirculation of the sternum following harvesting of the left internal mammary artery. Thorac Cardiovasc Surg (2003) 0.95
Video-assisted minimally invasive approach in clinical bilateral lung transplantation. J Thorac Cardiovasc Surg (2001) 0.95
Pulsatile perfusion and cardiomyocyte viability in a solid three-dimensional matrix. Biomaterials (2003) 0.95
In vitro engineering of heart muscle: artificial myocardial tissue. J Thorac Cardiovasc Surg (2002) 0.94
Mitral valve replacement with preservation of papillary muscles and chordae tendineae - revival of a seemingly forgotten concept. I. Preliminary clinical report. Thorac Cardiovasc Surg (1983) 0.94
Engineering of human vascular aortic tissue based on a xenogeneic starter matrix. Transplantation (2000) 0.93
Single-channel properties of L-type calcium channels from failing human ventricle. Cardiovasc Res (1998) 0.93
Status of patients presently living 9 to 13 years after orthotopic heart transplantation. Ann Thorac Surg (1997) 0.93
Inhaled nitric oxide and inhaled prostaglandin E1: effect on left ventricular contractility when used for treatment of experimental pulmonary hypertension. Eur J Cardiothorac Surg (1998) 0.92